The following is a summary of the Vext Science, Inc. (VEXTF) Q1 2024 Earnings Call Transcript:

Financial Performance:

• Vext Science recorded Q1 2024 revenue of $8.4 million, steady quarter-over-quarter but down year-over-year.

• Adjusted EBITDA for the quarter rose to $1.9 million, up from $0.5 million in the previous quarter, with margins at 23.3%.

• The rise in Q1 operating expenses compared to last year was due to increased depreciation related to Ohio and Eloy cultivation facilities and non-cash amortization expenses.

• The company closed the quarter with a cash balance of $4.5 million and has a standby credit facility of $2 million for additional liquidity.

Business Progress:

• Wholesale operations in Ohio saw strong growth, expecting to be boosted further with the imminent introduction of adult-use sales.

• Despite the decline in revenue in Arizona, the company outperformed state averages, supported by its vertically integrated operations.

• The fully-operational Eloy facility provides scope for expansion to increase the company's retail footprint in the market over the next few years.

• Vext is preparing to expand operations in Ohio, with potential for a third-party wholesale business, and is also preparing for a rapid transition to adult-use licensing in the state.

• The pending acquisition and launch of adult-use sales in Ohio is anticipated to make Vext a larger, more diversified operator with significant potential across limited-licensed states.

More details: VEXT SCIENCE INC IR

Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.